Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Treatment and survival analyses of malignant mesothelioma in Japan.

Gemba K, Fujimoto N, Aoe K, Kato K, Takeshima Y, Inai K, Kishimoto T.

Acta Oncol. 2013 May;52(4):803-8. doi: 10.3109/0284186X.2012.709948. Epub 2012 Aug 29.

PMID:
22928694
2.

Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.

Linton A, Pavlakis N, O'Connell R, Soeberg M, Kao S, Clarke S, Vardy J, van Zandwijk N.

Br J Cancer. 2014 Oct 28;111(9):1860-9. doi: 10.1038/bjc.2014.478. Epub 2014 Sep 4.

3.

Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?

Balduyck B, Trousse D, Nakas A, Martin-Ucar AE, Edwards J, Waller DA.

Ann Thorac Surg. 2010 Mar;89(3):907-11. doi: 10.1016/j.athoracsur.2009.12.041.

PMID:
20172152
4.

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.

Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG.

J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-63. doi: 10.1016/j.jtcvs.2012.12.037. Epub 2013 Feb 21.

5.

The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Deraco M, Baratti D, Hutanu I, Bertuli R, Kusamura S.

Ann Surg Oncol. 2013 Apr;20(4):1093-100. doi: 10.1245/s10434-012-2845-x. Epub 2013 Mar 2.

PMID:
23456386
6.

Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006.

Barbieri PG, Marinaccio A, Ferrante P, Scarselli A, Pinelli V, Tassi G.

Tumori. 2012 Mar-Apr;98(2):215-9. doi: 10.1700/1088.11932.

PMID:
22677987
7.

Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England.

Damhuis RA, Khakwani A, De Schutter H, Rich AL, Burgers JA, van Meerbeeck JP.

Lung Cancer. 2015 Aug;89(2):212-7. doi: 10.1016/j.lungcan.2015.05.014. Epub 2015 May 22.

PMID:
26044908
8.

Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.

Elkiran ET, Kaplan MA, Sevinc A, Aksoy S, Demirci U, Seker M, Harputluoglu H, Ozdemir NY, Isik F, Ulas A, Inanc M, Arslan UY, Dogu GG, Isikdogan A, Buyukberber S; Anatolian Society of Medical Oncology Group.

Med Oncol. 2012 Dec;29(5):3147-54. doi: 10.1007/s12032-012-0276-y. Epub 2012 Jun 22.

PMID:
22722923
9.

Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma.

Muruganandan S, Alfonso H, Franklin P, Shilkin K, Segal A, Olsen N, Reid A, de Klerk N, Musk AB, Brims F.

Br J Cancer. 2017 Mar 14;116(6):703-708. doi: 10.1038/bjc.2017.20. Epub 2017 Feb 14.

PMID:
28196068
10.

Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.

Beckett P, Edwards J, Fennell D, Hubbard R, Woolhouse I, Peake MD.

Lung Cancer. 2015 Jun;88(3):344-8. doi: 10.1016/j.lungcan.2015.03.005. Epub 2015 Mar 30.

PMID:
25863904
11.

The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma.

Nakas A, Waller D, Lau K, Richards C, Muller S.

Eur J Cardiothorac Surg. 2012 Jul;42(1):72-6; discussion 76. doi: 10.1093/ejcts/ezr251. Epub 2012 Jan 26.

PMID:
22290929
12.

Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.

Neragi-Miandoab S, Richards WG, Sugarbaker DJ.

Int J Surg. 2008 Aug;6(4):293-7. doi: 10.1016/j.ijsu.2008.04.004. Epub 2008 May 1.

13.

Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.

Kadota K, Suzuki K, Sima CS, Rusch VW, Adusumilli PS, Travis WD.

J Thorac Oncol. 2011 May;6(5):896-904. doi: 10.1097/JTO.0b013e318211127a.

14.

Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma.

Ceresoli GL, Locati LD, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, Zannini P, Bolognesi A, Villa E.

Lung Cancer. 2001 Nov;34(2):279-87.

PMID:
11679187
15.

Survival after conservative (palliative) management of pleural malignant mesothelioma.

Merritt N, Blewett CJ, Miller JD, Bennett WF, Young JE, Urschel JD.

J Surg Oncol. 2001 Nov;78(3):171-4.

PMID:
11745800
16.

Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma.

Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME.

J Surg Oncol. 1999 Jan;70(1):6-12.

PMID:
9989414
17.

Survival from malignant mesothelioma: where are we now?

Marshall AD, Bayes HK, Bardgett J, Wedderburn S, Kerr KM, Currie GP.

J R Coll Physicians Edinb. 2015;45(2):123-6. doi: 10.4997/JRCPE.2015.207.

PMID:
26181527
18.

Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.

Borasio P, Berruti A, Billé A, Lausi P, Levra MG, Giardino R, Ardissone F.

Eur J Cardiothorac Surg. 2008 Feb;33(2):307-13. doi: 10.1016/j.ejcts.2007.09.044.

PMID:
18164622
19.

Patterns of failure following surgical resection for malignant pleural mesothelioma.

Jänne PA, Baldini EH.

Thorac Surg Clin. 2004 Nov;14(4):567-73. Review.

PMID:
15559064
20.

[Experience in treating patients with malignant pleural mesothelioma].

Uramoto H, Shimokawa H, Baba T, Shigematsu Y, Nagata Y, Ono K, Takenoyama M, Hanagiri T.

J UOEH. 2010 Sep 1;32(3):257-64. Japanese.

PMID:
20857819

Supplemental Content

Support Center